These M2 TAMs also modulate the expression of programmed cell death-ligand 1 (PD-L1) on both tumor cells and infiltrating immune cells, contributing to immune evasion and disease progression in NSCLC patients [44,45]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.